Drug recall · August 7, 2013
Ranitidine Syrup recall
Why: Failed Impurity/Degradation Specification; "Related Compound C"
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactured by VistaPharm, Inc., Birmingham, AL 35242. Distributed by Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28092 USA
- Lots / codes
Lot Numbers: 247900, 251000, 256000, 261200, 263600, 266700, 277100, 280300 and 284300.
- Quantity
- A total of 133,968 bottles (units)
- Company
- Actavis South Atlantic LLC, Sunrise, FL
- Distribution
- Nationwide
- Initiated
- May 15, 2013 · Voluntary: Firm initiated
- Classified
- July 30, 2013
- Reported
- August 7, 2013
- Ended
- May 15, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ranitidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.